FORTE BIOSCIENCES, INC. Payments of Financing Costs
FORTE BIOSCIENCES, INC. (FBRX) reported Payments of Financing Costs of $10.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-12
- FORTE BIOSCIENCES, INC. payments of financing costs for the quarter ending 2026-06-30 was $10.56M, a 127.20% increase year-over-year.
- FORTE BIOSCIENCES, INC. payments of financing costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. payments of financing costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. payments of financing costs for the quarter ending 2025-09-30 was $475.00K.
- FORTE BIOSCIENCES, INC. payments of financing costs for fiscal 2025 was $7.44M, a 563.78% increase from fiscal 2024.
- FORTE BIOSCIENCES, INC. payments of financing costs for fiscal 2024 was $1.12M, a 312.13% increase from fiscal 2023.
- FORTE BIOSCIENCES, INC. payments of financing costs for fiscal 2023 was $272.00K.
- FORTE BIOSCIENCES, INC. payments of financing costs for fiscal 2021 was $106.00K, a 63.32% decline from fiscal 2020.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $10.56M 10-Q · filed 2026-08-12 | $10.56M derived: sum of 3 quarters · filed 2026-08-12 | $11.04M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $475.00K derived: sum of 3 quarters · filed 2026-05-11 | $5.13M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $475.00K derived: sum of 2 quarters · filed 2026-03-31 | $5.13M derived: sum of 3 quarters · filed 2026-08-12 | $7.44M 10-K · filed 2026-03-31 |
| 2025-09-30 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.13M derived: sum of 2 quarters · filed 2026-08-12 | $7.44M 10-Q · filed 2025-11-14 | $8.56M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $4.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $6.97M 10-Q · filed 2026-08-12 | $8.09M derived: sum of 3 quarters · filed 2026-08-12 | $8.09M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $2.32M 10-Q · filed 2026-05-11 | $3.44M derived: sum of 2 quarters · filed 2026-05-11 | $3.44M derived: sum of 3 quarters · filed 2026-05-11 | |
| 2024-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.12M derived: sum of 2 quarters · filed 2026-03-31 | $1.12M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $272.00K 10-K · filed 2025-03-28 | |||
| 2022-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $156.00K 10-Q · filed 2023-08-14 | $196.00K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $46.00K 10-Q · filed 2023-05-15 | $86.00K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $106.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $66.00K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $289.00K 10-K · filed 2022-03-31 |